Cargando…

A metabolite panel that differentiates Alzheimer's disease from other dementia types

INTRODUCTION: Alzheimer's disease (AD) is associated with altered metabolites. This study aimed to determine the validity of using circulating metabolites to differentiate AD from other dementias. METHODS: Blood metabolites were measured in three data sets. Data set 1 (controls, 27; AD, 28) was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Longfei, Yang, Jianwei, Zhu, Min, Pang, Yana, Wang, Qi, Wei, Qin, Li, Ying, Li, TingTing, Li, Fangyu, Wang, Qigeng, Li, Yan, Wei, Yiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545206/ https://www.ncbi.nlm.nih.gov/pubmed/34786838 http://dx.doi.org/10.1002/alz.12484

Ejemplares similares

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
por: Jia, Longfei, et al.
Publicado: (2021)

Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer’s disease
por: Cai, Huimin, et al.
Publicado: (2022)

A blood-based composite panel that screens Alzheimer’s disease
por: Wang, Yan, et al.
Publicado: (2023)

Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
por: Jia, Longfei, et al.
Publicado: (2020)

The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease
por: Jia, Longfei, et al.
Publicado: (2020)

A circular RNA blood panel that differentiates Alzheimer’s disease from other dementia types
por: Ren, Ziye, et al.
Publicado: (2022)

Detection of plasma Aβ seeding activity by a newly developed analyzer for diagnosis of Alzheimer’s disease
por: Jia, Jianping, et al.
Publicado: (2022)

Association of accelerated long-term forgetting and senescence-related blood-borne factors in asymptomatic individuals from families with autosomal dominant Alzheimer’s disease
por: Yang, Jianwei, et al.
Publicado: (2021)

Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial
por: Jia, Jianping, et al.
Publicado: (2018)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial
por: Head, Katharine J, et al.
Publicado: (2022)

Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer’s disease
por: Li, Wenwen, et al.
Publicado: (2023)

Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia
por: Willis, Brian A., et al.
Publicado: (2018)

Age‐stratified longitudinal study of Alzheimer's and vascular dementia patients
por: Jørgensen, Isabella Friis, et al.
Publicado: (2020)

Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease
por: Quan, Meina, et al.
Publicado: (2020)

Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias
por: Disbrow, Elizabeth, et al.
Publicado: (2021)

Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis
por: Maserejian, Nancy, et al.
Publicado: (2021)

Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer’s disease
por: Qin, Wei, et al.
Publicado: (2021)

Identification of KIAA0513 and Other Hub Genes Associated With Alzheimer Disease Using Weighted Gene Coexpression Network Analysis
por: Zhu, Min, et al.
Publicado: (2020)

The other superbugs
por: Fleming, Nic
Publicado: (2021)

Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias
por: Jiang, Jiehui, et al.
Publicado: (2022)

Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging
por: Jiang, Yuanbing, et al.
Publicado: (2021)

Expanding the scope of health disparities research in Alzheimer's disease and related dementias: Recommendations from the “Leveraging Existing Data and Analytic Methods for Health Disparities Research Related to Aging and Alzheimer's Disease and Related Dementias” Workshop Series
por: Akushevich, Igor, et al.
Publicado: (2023)

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials
por: Xu, Steven X., et al.
Publicado: (2015)

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
por: Herring, W. Joseph, et al.
Publicado: (2020)

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group
por: Verberk, Inge M. W., et al.
Publicado: (2021)

Neurovascular and immune mechanisms that regulate postoperative delirium superimposed on dementia
por: Wang, Ping, et al.
Publicado: (2020)

A pandemic like no other
por: Goodman, Jonathan R.
Publicado: (2021)

Midlife lipid and glucose levels are associated with Alzheimer's disease
por: Zhang, Xiaoling, et al.
Publicado: (2022)

Inferior parietal transcranial direct current stimulation with training improves cognition in anomic Alzheimer's disease and frontotemporal dementia
por: Roncero, Carlos, et al.
Publicado: (2017)

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia
por: Gault, Laura M., et al.
Publicado: (2015)

Opioid use and the presence of Alzheimer's disease and related dementias among elderly Medicare beneficiaries diagnosed with chronic pain conditions
por: Shen, Chan, et al.
Publicado: (2018)

Association of life‐course traumatic brain injury with dementia risk: A nationwide twin study
por: Zhang, Lulu, et al.
Publicado: (2022)

The Other Half of the Story: Effect Size Analysis in Quantitative Research
por: Maher, Jessica Middlemis, et al.
Publicado: (2013)

Shared and unique effects of ApoEε4 and pathogenic gene mutation on cognition and imaging in preclinical familial Alzheimer’s disease
por: Quan, Meina, et al.
Publicado: (2023)

Temporal association of neuropsychological test performance using unsupervised learning reveals a distinct signature of Alzheimer's disease status
por: Joshi, Prajakta S., et al.
Publicado: (2019)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Body brain life: A randomized controlled trial of an online dementia risk reduction intervention in middle-aged adults at risk of Alzheimer's disease
por: Anstey, Kaarin J., et al.
Publicado: (2015)

Safety Risks Among Home Infusion Nurses and Other Home Health Care Providers
por: Markkanen, Pia, et al.
Publicado: (2017)

Using data science to diagnose and characterize heterogeneity of Alzheimer's disease
por: Ang, Ting F.A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_opc0b82hni709c59mtereshlpl